NSC 628503
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Taxotere (TER) and tax01 (TA) are new antitumour agents currently undergoing clinical evaluation. We studied the antineoplastic…
SummaryDocetaxel (Taxotere®, RP 56976, NSC 628503), a new taxoid, was evaluated for preclinical evidence of anticancer activity…
In the late 1960s, a crude alcohol extract from the bark of the Pacific Yew, Taxus brevifolia L., was revealed to be cytotoxic in…
PURPOSE
This phase I study of Taxotere (RP 56976, NSC 628503; docetaxel, Rhône-Poulenc Rorer, Antony, France) was undertaken to…
Taxotere (N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl Taxol; RP 56976; NSC 628503) is a semisynthetic analogue of Taxol. It is…
BACKGROUND
The new cytostatic agent taxol has clearly demonstrated its effectiveness in ovarian cancer patients. The synthesis of…
Taxotere (RP 56976, NSC 628503) is a new semisynthetic analog of taxol (NSC 125973) with promising antitumor activity in a…